Investigation of Quetiapine Form I
Martin
Vickers
14th September 2004
Experimental Data
Click image to access powder diffraction data (.spf format)
Chemical Name
11-[4-/2-(2-hydroxyethoxy)ethyl/-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine
Chemical Formula
C21H25N3O2S |

|
Preparation and Instrumentation Parameters
- Stoe StadiP transmission (capillary) Powder Diffractometer
- Cu Kα1 X-ray radiation
- Pre-sample germanium monochromator
- 40kV/30mA generator power
- Linear Position Sensitive Detector 6° 2θ range
- Rotating 0.5mm sample capillary
- uncrushed, unsieved sample
- NBS Silicon (111 reflection) calibration
- Data aquisition details:
- Date collected: 10/09/04
- File: ST1180.RAW
- ×2 ranges from 5 to 35° 2θ
- PSD step: 0.1°
- Count Time: 100 seconds per step
- Binning: 4 channels per point
- Data Step: 0.02°
Results
- Indexed using ITO12
- Refined lattice parameters by Lebail fit:
| Unit Cell Lengths (Å): |
|
a 11.965(1) |
b 13.228(1) |
c 13.962(1) |
|
| Unit Cell Angles (°): |
|
α 90 |
β 92.292(1) |
γ 90 |
| Unit Cell Volume (Ų): |
| 2208 |
- Z: 4
- System: Monoclinic
- Possible Space Group: P21/c
Reference
World Patent: WO0155125A1